Pulmonary aneurysms and intracardiac thrombi due to Behçet's disease in an African-American adolescent with oculocutaneous albinism

Clinical Rheumatology

Volumn 26, Issue 9, 2007, Pages 1537-1539

  Endo, Lois M ^a   Rowe, Steven M ^a   Romp, Robb L ^a   Buckmaster, Mark A ^a   Atkinson, T Prescott ^b  

^a University of Alabama at Birmingham   (United States)

^b CHILDREN S HOSPITAL   (United States)

Author keywords

Albinism; Beh et's disease; Infliximab; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; DOUBLE STRANDED DNA ANTIBODY; ENOXAPARIN; INFLIXIMAB; LUPUS ANTICOAGULANT; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISONE; RHEUMATOID FACTOR; UROKINASE;

ADOLESCENT; AFRICAN AMERICAN; ARTERY THROMBOSIS; ARTICLE; BEHCET DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEMOPTYSIS; HUMAN; INTRACARDIAC THROMBOSIS; MAINTENANCE THERAPY; OCULOCUTANEOUS ALBINISM; POPLITEAL ARTERY; PRIORITY JOURNAL; PULMONARY ARTERY ANEURYSM; THROMBECTOMY;

ADOLESCENT; AFRICAN AMERICANS; ALBINISM, OCULOCUTANEOUS; ANEURYSM; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; FEMALE; HEART DISEASES; HUMANS; PULMONARY ARTERY; THROMBOSIS; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 34547578100     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-006-0426-8     Document Type: Article

References (16)

1. Kurokawa S, Suzuki N (2004) Behçet's disease. Clin Exp Med 4:10-20
2. Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behçet's disease. N Engl J Med 341:1284-1291
3. Krause I, Uziel Y, Guedj D, Mukamel M, Harel L, Molad Y, Weinberger A (1999) Childhood Behçet's disease: Clinical features and comparison with adult-onset disease. Rheumatol 38:457-461
4. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
5. Azizlerli G (2005) Juvenile Behçet's syndrome. In: Cassidy J, Petty R (eds) Textbook of pediatric rheumatology. Elsevier Saunders, Philadelphia
6. Koné-Paut L, Yudakul S, Bahabri S, Shafae N, Ozen S, Ozdogan H, Bernard J (1998) Clinical features of Behçet's disease in children: An international collaborative study of 86 cases. J Pediatr 132:721-725
7. Leiba M, Seligsohn U, Sidi Y, Harats D, Sela BA, Griffin JH, Livneh A, Rosenberg N, Gelernter I, Gur H, Ehrenfeld M (2004) Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 63:1445-1449
8. Uzun O, Akpolat T, Erkan L (2005) Pulmonary vasculitis in Behçet's disease: A cumulative analysis. Chest 127:2243-2253
9. Erkan F, Kiyan E, Tunaci A (2002) Pulmonary complications of Behçet's disease. Clin Chest Med 23:493-503
10. Azteni F, Sarzi-Puttini P, Doria A, Boiardi L, Pipitone N, Salvarani S (2005) Behçet's disease and cardiovascular involvement. Lupus 14:723-726
11. Connolly M, Armstrong JS, Buckley DA (2005) Infliximab treatment for severe orogenital ulceration in Behçet's disease. Br J Rheumatol 153:1073-1075
12. Tugal-Tutkun I, Mudun A, Urgancioglu M, Kamali S, Kasapoglu E, Inanc M, Gul A (2005) Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclosporine, and corticosteroids in Behçet's disease: An open-label trial. Arthritis Rheum 52:2478-2484
13. Sarwar H, McGrath H Jr, Espinoza LR (2005) Successful treatment of long-standing neuro-Behçet's disease with infliximab. J Rheumatol 32:181-183
14. Wechsler B, Sable-Fourtassou R, Bodaghi B, Huong DL, Cassoux N, Badelon I, Fain O et al (2004) Infliximab in refractory uveitis due to Behçet's disease. Clin Exp Rheumatol 22(Suppl 34):S14-S16
15. Ohno S, Nakamura S, Hori S, Shimakawa M, Kawashima H, Mochizuki M, Sugita S et al (2004) Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol 31:1362-1368
16. Saulsbury F, Mann J (2003) Treatment with infliximab for a child with Behçet's disease. Arthritis Rheum 49:599-600